We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Test for Alcohol Abuse

By HospiMedica staff writers
Posted on 06 Feb 2002
An improved test for carbohydrate-deficient transferrin (CDT), for the identification of alcohol abuse, features higher sensitivity, shorter turn-around time, and temperature independence, as compared to the original test.

The test, a heterogeneous immunoassay, is the most reliable and specific biomarker available on the market for identifying heavy alcohol consumption, says Bio-Rad Laboratories, Inc. More...
(Hercules, CA, USA), which developed the test. The benefit of its test, called %CDT TIA, is that few conditions other than heavy drinking will cause CDT to be elevated. The improved version is more specific than its forerunner and is 20 minutes shorter. Also, it can be run within a broader range of ambient temperatures. Both tests measure the amount of CDT in proportion to total transferrin.

Bio-Rad notes that the test has been used by transportation companies and alcohol treatment centers in Europe and elsewhere abroad and by the US insurance industry. Alcohol treatment programs can also use the test to identify alcohol use and refine intervention strategies when relapse occurs. The test kits have been cleared by the US Food and Drug Administration (FDA).




Related Links:
Bio-Rad

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new, inexpensive stick-on sweat sensor measures lipid levels, offering a noninvasive way to continuously monitor cholesterol and triglycerides. (Image Credit: California Institute of Technology)

Wearable Patch Enables Continuous Noninvasive Cholesterol and Triglyceride Monitoring

Cholesterol and triglyceride testing typically relies on phlebotomy and intermittent lipid panels, limiting real-time assessment of cardiovascular and metabolic risk. Noninvasive monitoring could reduce... Read more

Surgical Techniques

view channel
Image: Phasix Mesh is a fully resorbable monofilament scaffold designed for rapid tissue incorporation, combining synthetic mesh repair strength with biologic graft-like remodeling. (Photo courtesy of BD)

Resorbable Mesh Evaluated to Prevent Incisional Hernias After Abdominal Surgery

Incisional hernia is a common complication after abdominal surgery and can necessitate additional interventions and prolonged recovery. Preventive strategies remain limited, and there are currently no... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.